Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1CNS 1

Conditions

Glioma 3Central Nervous System Neoplasms 3Astrocytoma 3Oligodendroglioma 2Neurofibromatosis 1 2Brain Neoplasms 2Rhabdoid Tumor 1Recurrence 1Precancerous Conditions 1Optic Nerve Glioma 1Neurofibroma, Plexiform 1Neoplasms 1Melanoma 1Gliosarcoma 1Glioma, Subependymal 1Glioblastoma 1Ependymoma 1Choroid Plexus Neoplasms 1

Interventions

AZD 6244 11trametinib 4pirfenidone 3mirdametinib 2dabrafenib 2cabozantinib 2Imatinib Mesylate 2tipifarnib 1peginterferon alfa-2b 1nilotinib 1cediranib 1binimetinib 1Vinblastine 1Surveys and Questionnaires 1Sorafenib 1Pharmacokinetics 1Methotrexate 1Liquid Biopsy 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Everolimus 1Cryotherapy 1Control Groups 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibroma, Plexiform × Vinblastine × CNS × Clear all
NCT00030264 2018-08-08

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Children's Hospital of Philadelphia

Phase 2 Completed
23 enrolled 9 charts
CNSOther neoplasm

Neurofibromatosis 1, Precancerous Conditions, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡